Blood Immunology & Cellular Therapy Medicine
Duffy null status predicts severe neutropenia after ciltacabtagene autoleucel but not other BCMA therapies in myeloma
The publisher did not provide an abstract — full text is available via the link below.
Blood Immunology & Cellular Therapy Medicine
The publisher did not provide an abstract — full text is available via the link below.